PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY

Oct 1, 2018, 00:00 AM

10.1016/j.jval.2018.09.216

https://www.valueinhealthjournal.com/article/S1098-3015(18)33516-2/fulltext

Section Title :

Section Order : 1557

First Page :

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33516-2&doi=10.1016/j.jval.2018.09.216

HEOR Topics :

Tags :

Regions :